Clinical Trial: A randomized, open-label, parallel-controlled, multicenter phase III clinical study of CD25 monoclonal antibody in preventing acute graft-versus-host disease after haploidentical hematopoietic stem cell transplantation (China)

China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized, open-label, parallel-controlled, multicenter phase III clinical study of CD25 monoclonal antibody in preventing acute graft-versus-host disease after haploidentical hematopoietic stem cell transplantation'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133108

Registration Time: 2026/09/22

Type: Interventional study

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344728

Published by HT Digital Content Services with permission from Healt...